PDF
File
Kurs & Likviditet
Beskrivning
| Land | Danmark |
|---|---|
| Lista | First North Denmark |
| Sektor | Hälsovård |
| Industri | Vård & Omsorg |
Copenhagen, Denmark October 7, 2022 - Brain+ A/S (Nasdaq First North: BRAINP)
The pricing period for Brain+'s warrants of series TO 1 (BRAINP TO, ISIN: DK0061670551) is underway. These warrants will from October 17[th] to October 31[st] be exercisable into newly issued Brain+ A/S shares at a 30% discount to the volume-weighted average price of shares traded from October 3[rd] to October 14[th], 2022.
Relevant information is now available on our website
To help investors, Brain+ has created a sub-page on its website with relevant information in single place. The page is now live for investors to access, and provides details on the upcoming warrant exercise.
Investors can access the page on Brain+'s website (www.brain-plus.com) or through this direct link: https://www.brain-plus.com/exercise-of-warrants/.
Once the warrant pricing period ends on October 14[th] 2022, Brain+ will announce the exercise price in a separate company announcement.
Contact Information
CEO, Kim Baden-Kristensen + 45 31393317, E-mail: kim@brain-plus.com,Brain+ A/S, Købmagergade 53, 3.
Certified Advisor: Keswick Global AG, + 43 1 740 408045, E-mail: info@keswickglobal.com (%20info@keswickglobal.com)